/Bio-Rad%20Laboratories%20Inc_%20logo%20and%20site-by%20T_Schneider%20via%20Shutterstock.jpg)
Bio-Rad Laboratories is expected to release its fiscal second-quarter earnings next month, and analysts project a double-digit profit dip.
/Becton%20Dickinson%20%26%20Co_%20BACTEC%20by-%20TheBlueHydrangea%20via%20Shutterstock.jpg)
Becton, Dickinson and Company is all set to release its fiscal third-quarter earnings next month, and analysts expect a double-digit profit increase.
/Edwards%20Lifesciences%20Corp%20phone%20and%20logo%20-by%20T_Schneider%20via%20Shutterstock.jpg)
Edwards Lifesciences is expected to release its second-quarter earnings this month, and analysts expect a single-digit profit increase.
/Align%20Technology%2C%20Inc_%20invisable%20aligners-%20by%20Alexandr%20Grant%20via%20Shutterstock.jpg)
Align Technology is all set to release its second-quarter earnings this month, and analysts project a high-single-digit bottom-line increase.
/Dexcom%20Inc%20HQ-by%20JHVEPhoto%20via%20Shutterstock.jpg)
Despite DexCom’s underperformance compared to its industry, Wall Street analysts remain optimistic about the stock’s prospects.
You don't need to be a stock market expert to earn above-average returns.
/Abbott%20Laboratories%20HQ%20photo-%20by%20Sundry%20Photography%20via%20iStock.jpg)
Despite Abbott’s recent underperformance over the past year, Wall Street analysts remain optimistic about the stock’s prospects.
/Abbott%20Laboratories%20vials%20and%20Logo-by%20Melniov%20Dmitriy%20via%20Shutterstock.jpg)
Abbott has underperformed the broader market over the past year, but Wall Street analysts are optimistic about the stock’s prospects.
Medtronic has underperformed the broader market over the past year, but Wall Street analysts are still moderately bullish about the stock’s prospects.
Despite Baxter International’s relatively underwhelming performance over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.